Showing 381 - 400 results of 1,860 for search 'significantly elevated decrease', query time: 0.34s Refine Results
  1. 381
  2. 382
  3. 383
  4. 384

    Ozone-Induced Alterations in Rhizospheric Nitrogen Pools and Their Implications for N<sub>2</sub>O Emissions in Rice Soil by Ziom Adam Michael (21751928)

    Published 2025
    “…<p>Elevated tropospheric ozone (O<sub>3</sub>) may alter nitrous oxide (N<sub>2</sub>O) emissions from rice soils by affecting soil nitrogen pools and microbial activity. …”
  5. 385
  6. 386
  7. 387

    Data Sheet 1_Dual variants of uncertain significance in a case of hyper-IgM syndrome: implications for diagnosis and management.pdf by Nourhen Agrebi (14151222)

    Published 2025
    “…Background<p>Hyper-IgM syndrome (HIGM) is a genetic immunodeficiency characterized by elevated to normal IgM levels and decreased IgG, IgA, and IgE. …”
  8. 388
  9. 389
  10. 390
  11. 391
  12. 392
  13. 393
  14. 394
  15. 395

    The original plotting data for Fig 7. by Haoxuan Xue (19949764)

    Published 2024
    “…PCOS rats displayed disrupted estrous cycles, increased weight, elevated serum testosterone, cystic follicles, granulosa cell layer thinning, and reduced corpora lutea count (<i>P</i> are all less than 0.05). …”
  16. 396

    Primer sequences used for the qRT-PCR analysis. by Haoxuan Xue (19949764)

    Published 2024
    “…PCOS rats displayed disrupted estrous cycles, increased weight, elevated serum testosterone, cystic follicles, granulosa cell layer thinning, and reduced corpora lutea count (<i>P</i> are all less than 0.05). …”
  17. 397

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”
  18. 398

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”
  19. 399

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”
  20. 400

    Study selection flow diagram. by Laurence Weinberg (2960238)

    Published 2025
    “…</p><p>Conclusions</p><p>Although age alone should not preclude nonagenarians from undergoing cardiac surgery, the procedure is associated with a significantly elevated risk of morbidity and a relatively high mortality rate. …”